Vetpharma Limited - Due diligence report

A 360° intelligence report on Vetpharma Limited: trust score, financial health, credit view, compliance, directors, growth and distress sign…

1995-05-08 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
View plans Plan
VL Vetpharma Limited
View plans Plan
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Vetpharma Limited — 360° Intelligence Report

Generated from MCA filings & public records
70/100
Trust Score
Moderate

Vetpharma Limited is assessed as Moderate with a Trust Score of 70/100. Vetpharma Limited is an active public limited indian non-government company incorporated in 1995, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 09 Jul 2026 from the latest processed filings. Vetpharma Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
70/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
20/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
55/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 5 satisfied (36.10 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others5 48.0 cr
Compliance Score: 93/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
  • 1 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
MUKESH DHIRUBHAI NAIK 01234567 Director 01/04/2018 6 yrs Approved
UDAY DESAI MUKESH 01234567 Director 01/04/2018 6 yrs Approved
DILIP KAMALAKAR PIMPLE 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2015)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2021 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)

Promoters hold the largest single block of equity - exact percentages are part of the full report.

Group entityRelationship% held
Uday Chemical Engineers And Projects Limited Associate Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 55
Growth signals & trust indicators
Latest year revenue grew 38%.
Operating for 31+ years.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Negative net worth.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence75/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment50/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view44/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
29 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
16 Jun 2020
Charge satisfied
Others
26 Dec 2016
Charge created
Others - 5.00 cr
05 Aug 2016
Director ceased
PARESH MOHANBHAI DESAI
05 Jul 2016
Director appointed
MUKESH DHIRUBHAI NAIK (Additional Director)
14 Mar 2016
Charge created
Others - 6.40 cr
10 Mar 2016
Charge created
Others - 10.00 cr
Charge created
Others - 1.00 cr
Charge created
Others - 13.70 cr
21 Jan 2016
Director ceased
GITA MUKESH NAIK
31 Jul 2009
Securities allotted
260000.00 Equity Shares - 1.30 cr raised
31 Mar 2009
Securities allotted
141125.00 Equity Shares - 56.45 Lakh raised
15 Mar 2002
Director appointed
UDAY DESAI MUKESH (Director)
23 Feb 1998
Director appointed
DILIP KAMALAKAR PIMPLE (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 5 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold the largest single block of equity as per the FY 2021 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Lipsa Chemicals Private Limited U24100WB2010PTC144770 Haringhata, West Bengal, India
Lumiradx Healthcare Private Limited U33309MH2021FTC363513 Mumbai, Maharashtra, India
Dennis Pharma Private Limited U24290WB2019PTC229639 Howrah, West Bengal, India
Quester Chemicals (India) Private Limited U24233MH2012PTC228415 Sinnar, Maharashtra, India
Artesa Living Private Limited U74102DL2020PTC370484 Newdelhi, Delhi, India
Versatile Specialty Chemicals Limited U24233MH2012PLC228037 Dhule, Maharashtra, India
Cashewona (India) Private Limited U24100UP2016PTC087460 Ghaziabad, Uttar Pradesh, India
S. V. Coatings Private Limited U24222KA2007PTC044749 Bangalore, Karnataka, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Vetpharma Limited before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Vetpharma Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 50/100, margin trends, ownership structure and peer set for Vetpharma Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 70/100, distress signals and MSME payment-delay disclosures - know whether Vetpharma Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Vetpharma Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Vetpharma Limited an active company?

Vetpharma Limited has MCA status “Active” with a compliance score of 93/100 (Low Risk).

Is Vetpharma Limited financially healthy?

Vetpharma Limited has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Vetpharma Limited?

Its overall Trust Score is 70/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Vetpharma Limited?

Promoters hold the largest single block of equity - exact percentages are in the full report. 3 active director(s) are on record.

Does Vetpharma Limited have loans or charges against its assets?

No open charges - all 5 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Vetpharma Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).

Is it risky to lend to Vetpharma Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.